Accelerating Biopharma Lab Execution With Digitalization
The growing complexity and diversity of their expanding product lines, as well as the acceleration of clinical trial processes, has put Chemistry, Manufacturing and Controls (CMC) teams on the critical path for commercial product launches.
See how one of the world’s largest biopharma companies accepted the challenge to implement a common solution across all CMC labs and for all therapeutic modalities – both small molecules and biologics. Built with BIOVIA Dassault Systèmes’ ONE Lab solution, a common platform for use across all drug substance, drug product and analytical development labs worldwide.